FDA approves Hologic’s Selenia 3D mammography system

HOLX logo

The plant inspection must have gone well, because the Food & Drug Administration approved Hologic Corp.’s (NSDQ:HOLX) one-of-a-kind 3d breast imaging platform, the Selenia, for performing mammograms.

Late last year, the federal watchdog agency told the Bedford, Mass.-based women’s health firm that only an inspection of its manufacturing facilities separated the company from a long-awaited approval of the system. It incorporates 3-D imaging with 2-D imaging for breast exams to give radiologists a clearer image with more data. The device’s tomosynthesis technology produces 3-D images by digitally combining multiple X-rays, alleviating the issues associated with distortion by tissue shadowing or density, according to the company.

"Physicians can now access this unique and innovative 3-D technology that could significantly enhance existing diagnosis and treatment approaches," Center for Devices & Radiological Health chief Dr. Jeffrey Shuren said in prepared remarks.

In September, the system won unanimous favorable votes from the the agency’s Radiological Devices Panel on effectiveness and safety and that the benefits of the system’s technology outweigh its risks. Hologic has been waiting for approval of its the system since it submitted a pre-market approval application in 2008. The Selenia won European certification in June.

The first Selenia systems sold for tomosynthesis are likely to hit the U.S. before insurers decide how to reimburse for its use, but the platform can be used just for 2-D while Hologic waits for the final reimbursement call on 3-D screening.

The approval comes just in time for Hologic, which saw first-quarter profits plunge 58 percent. The company reported net income of $10.9 million, or 4 cents per diluted share, on sales of $432.6 million during the three months ended Dec. 25, 2010. But with nearly 40 million mammograms performed each year, the market for the new device &m,dash; the first 3d mammography system cleared for the U.S. market — Hologic stands to make some hay while the sun shines. The National Cancer Institute estimates that nearly 200,000 women are diagnosed with breast cancer each year; one out of eight women are hit with a breast cancer diagnosis during their lifetime. When caught early, however, while it’s still localized in the breast, there’s a 98 percent survival rate. And 1 in 8 women will be diagnosed with breast cancer during their lifetime. There is a 98 percent survival rate when breast cancer is detected early and still localized to the breast.

Physicians polled for a pair of the studies the FDA used in making its decision reported a 7 percent improvement in their ability to distinguish between cancerous and non-cancerous cases as compared to viewing 2-D images alone, according to an agency press release. Although the system exposes patients to roughly double the radiation of standard 2D mammograms, the improved accuracy caused fewer women enrolled in the studies to be recalled for diagnostic workups, according the FDA. The agency estimated the increased cancer risk to be 1.5 percent "compared to the natural cancer incidence, and less than 1 percent compared to the risk from conventional 2-D mammography," according to the release, noting that "there is uncertainty for radiation risk estimates."

Docs looking to use the new platform must take a mandatory eight hours of training on the Selenia.

RSS From Medical Design & Outsourcing

  • Molex delivers ISO 13485-compliant, medical-grade surgical cables from its class 100,000 clean room facility
    Molex, LLC operates a fully ISO 146441-1:1999 Class 8-certified clean room, satisfying strict particulate contamination levels specified by ISO-compliant requirements. Located in Thailand, the facility has less than 100,000 particulates (≥0.5µm) per cubic foot of air and manufactures a variety of ISO 13485-compliant medical cables and surgical cables used in operating theatres, hospitals, laboratories and […]
  • Swept-Source OCT: Patent license agreement between Massachusetts General Hospital and Heidelberg Engineering
    Heidelberg Engineering has entered into a patent license agreement with Massachusetts General Hospital (MGH) in Boston. The agreement grants global and exclusive rights to 77 basic patents and patent applications which relate to swept-source OCT technology and its application in ophthalmology. Spectral domain OCT has become indispensable to eye care professionals worldwide to diagnose and […]
  • MIT’s MultiFab presents a stark challenge to incumbent 3D Printer manufacturers’ hardware, software, and business Models
    MIT’s Computational Fabrication Group recently announced the MultiFab, a low-cost 3D printer that can combine up to 10 different resins in one part and also includes a 3D scanning system to identify and fix errors during production. According to Lux Research, these capabilities are rare in commercial 3D printers today due to the manufacturers’ need […]
  • AVX releases Accu-P MP medical grade film chip capacitors for medical devices
    AVX Corporation, a leading manufacturer of passive components and interconnect solutions, has released a new series of thin film chip capacitors specifically designed to meet the demanding performance specifications for implantable medical devices. Delivering extremely tight capacitive tolerances, exceptionally repeatable performance, and remarkably low ESR and high Q at high frequencies—including VHF, UHF, and RF […]
  • RIVANNA commences manufacturing of its Accuro device
    Rivanna Medical announced that it has begun manufacturing its FDA-cleared Accuro device, a handheld and untethered smart-phone-sized device that is designed to guide spinal anesthesia with automated 3D navigation technology in addition to ultrasound imaging of abdominal, musculoskeletal, cardiac and peripheral vascular anatomies. The product will be launched at the ASA annual meeting in San […]
  • FDA seeks public input on Quality Metrics guidance
    by Oliver Wolf, Senior Product Manager, MasterControl In line with the general shift towards risk-driven approaches in the quality management world, FDA is now taking steps towards applying those same principles to its own auditing schedule. At the end of July, the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation […]
  • First ‘Ear Wear’ for Active Adults Debuts with MDHearingAid FIT
    If you’ve burned out your ears with earbuds, headphones or decades of other audio abuse but aren’t ready for your grandmother’s hearing aids, not to worry! The new MDHearingAid FIT gets you back in the game with a tiny, FDA-registered, one-size-fits-most solution that doesn’t block your ear canal like old-fashioned in-the-ear hearing aids. The FIT feels […]
  • CardioGenics enters into manufacturing agreement with Ontario-based Plasticap
    CardioGenics Holdings, developer for the In-Vitro-Diagnostics (“IVD”) testing market, announced that it has entered into a manufacturing agreement with Plasticap of Ontario, Canada, pursuant to which Plasticap will manufacture CardioGenics’ proprietary self-metering cartridges for its QL Care analyzer. The term of the agreement is three years and the purchase price for each cartridge shall be […]
  • MTD Micro Molding releases micro materials menu
    MTD Micro Molding, a long-time leader in micro-injection molding, has released an updated “Materials Menu” of materials that can be successfully micromolded to help guide engineers at medical device companies. Material selection is a crucial step in product manufacturability. The correct material drives tolerance, dimension, strength, usabality, speed-to-market, design, critical features, and cost. Through MTD’s […]
  • MedTech Chat: Elastic technology for drug delivery
    Dr. Zhen Gu and Dr. Yong Zhu from North Carolina State University are both co-senior authors of a research paper describing their recent work. Dr. Gu, Dr. Zhu and other researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed a drug delivery technology that consists of an […]
  • B. Braun’s OEM Division offers large bore normally closed low-pressure check valves
    Infusion therapy and pain management device manufacturer B. Braun said today it is offering normally closed large-bore low-pressure check valves through its valve-focused contract manufacturing OEM division. The valves, offered by Bethlehem, Pa.-based B. Braun, are designed for the intermittent injection of fluids during medical treatment and open automatically when pressure is applied. The newly […]

Leave a Reply